Gilder Gagnon Howe & Co’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.38M Buy
+32,833
New +$1.93M 0.03% 192
2022
Q1
Sell
-9,375
Closed -$551K 298
2021
Q4
$551K Buy
9,375
+36
+0.4% +$2.19K ﹤0.01% 318
2021
Q3
$567K Sell
9,339
-4
-0% -$235 ﹤0.01% 342
2021
Q2
$560K Buy
9,343
+2,913
+45% +$146K ﹤0.01% 350
2021
Q1
$303K Sell
6,430
-2,888
-31% -$119K ﹤0.01% 331
2020
Q4
$350K Sell
9,318
-36,799
-80% -$1.21M ﹤0.01% 293
2020
Q3
$1.51M Sell
46,117
-14,415
-24% -$610K 0.01% 253
2020
Q2
$2.75M Buy
60,532
+54,579
+917% +$2.79M 0.02% 206
2020
Q1
$272K Sell
5,953
-60
-1% -$2.71K ﹤0.01% 234
2019
Q4
$260K Buy
6,013
+512
+9% +$20.9K ﹤0.01% 258
2019
Q3
$199K Sell
5,501
-2,162
-28% -$91.1K ﹤0.01% 261
2019
Q2
$360K Sell
7,663
-1,202
-14% -$50.8K ﹤0.01% 254
2019
Q1
$312K Buy
8,865
+2,993
+51% +$118K ﹤0.01% 239
2018
Q4
$220K Buy
5,872
+36
+0.6% +$1.41K ﹤0.01% 236
2018
Q3
$198K Buy
+5,836
New +$171K ﹤0.01% 260
2016
Q3
Sell
-27,407
Closed -$586K 273
2016
Q2
$586K Buy
+27,407
New +$863K 0.01% 201

Other funds holding ATEX

Gilder Gagnon Howe & Co's ATEX Position: Q2 2026 in Review

Gilder Gagnon Howe & Co opened a new position in Anterix (ATEX) in Q2 2026: 32,833 shares worth $3.38M. The stake represents 0.03% of the portfolio and ranks #192 among its holdings. This is a return to the name: Gilder Gagnon Howe & Co previously reported a position in ATEX as recently as Q4 2021.

Gilder Gagnon Howe & Co first reported a position in ATEX in Q2 2016 and has held it in 16 quarters since. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Gilder Gagnon Howe & Co held 32,833 shares of Anterix worth $3.38M as of Q2 2026.
  • Anterix was a new Gilder Gagnon Howe & Co position in Q2 2026.
  • Anterix made up 0.03% of Gilder Gagnon Howe & Co's portfolio in Q2 2026, its #192 holding.
  • Gilder Gagnon Howe & Co first reported a position in Anterix in Q2 2016 and has held it in 16 quarters since.
  • 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2026, filed 14 Aug 2026.